Continuous and dynamic progress in all segments of transfusion medicine has significantly improved the quality, safety and efficacy of transfusion therapy. In addition to the scientific and technological innovations, implementation of the quality system and haemovigilance in blood establishments significantly contributed to this progress. Despite the fact that most of the activities in transfusion chain take place without problems, some risks are still present and even the best organized and managed systems are sometimes faced with quality problems and complaints. In transfusion medicine, their causes are mostly related to the biological origin of blood products, while the complexity of the process and a large number of participants in transfusion chain facilitates the occurrence of errors. Some quality problems are caused by materials and equipment used in product realization, inadequate education or skills of the staff, suboptimal planning and organization of work. The best approach to managing quality problems is preventative approach, including comprehensive risk management, education, defining critical control points, permanent quality monitoring and audits. Quality problems and complaints should be resolved in a timely manner, following the standardized protocol with clearly defined responsibilities. All procedures and decisions should be documented and traceable. The root cause analysis of the problem should be carried out and followed by appropriate corrective actions. The ultimate goal is to increase quality, safety, productivity, efficiency and customer satisfaction, while reducing defects and costs.
Introduction
According to many of its characteristics and features, transfusion medicine is a specific area of medical science. This particular position also entails the great responsibility of transfusion services to provide accessible and safe transfusion therapy.
Despite the tremendous progress in terms of quality and safety in transfusion medicine and the fact that most of the activities in transfusion chain take place without problems, some risks are still present. The biological origin of blood products may be the cause of transfusiontransmissible infections and immune-mediated transfusion reactions, while the complexity of the process and a large number of participants in transfusion chain facilitates the occurrence of errors. In addition to these examples of rare but potentially very dangerous events, there are also examples of more frequent nonconformities and other quality problems occurring during the realization of products and services. Even the quality problems with low potential to be serious may become serious, if not recognized on time and treated properly.
For all these reasons, it is important to ensure the proper functioning of all activities in the entire process of transfusion medicine, from 'vein to vein', and monitor them with different control mechanisms. The quality management system and haemovigilance significantly contribute to the safety and quality of transfusion therapy [1] [2] [3] . These systems have the role of preventing things from getting badly and when this happens to allow preventing and mitigating damage by a correct and rapid response.
Managing quality problems and complaintsgeneral principles
The best approach to managing quality problems is preventative approach, including comprehensive risk management, education, definition of critical control points, permanent quality monitoring, audits and identification of opportunities. Permanent quality monitoring using appropriate indicators enables timely detection of problems and risks within the institution and the implementation of appropriate corrective and preventive measures, all with the aim of continuous quality improvement [4] .
Responsibility for quality cannot be attributed to only one person or department. It is result of team efforts and co-operation. However, to prevent that everyone's responsibility becomes no one's responsibility, an independent function within the institution must be established, responsible to support, direct and supervise all quality-related activities. Management should define quality policy, set quality objectives and provide necessary resources for their realization, promote continuous improvement and education of staff in all aspects of quality management [5] .
In solving problems, it is very important to follow a standardized/structured protocol with clearly defined responsibilities and prescribed sequence of activities, and to ensure adequate transfer of information within the institution.
Quality problems and complaints should be resolved in a timely manner, and all procedures and decisions should be documented and traceable.
Although knowledge and professional competence are of critical importance in resolving problems, human qualities will greatly contribute to the success of this process.
In both private and professional life, we have to make a number of decisions on a daily basis. Fortunately, most of these decisions are routine and simple. The problem arises when we have to make decisions in situations of lacking or inadequate information, insufficient time, poor communication, uncertainty, facing complex problems or when decisions may have serious consequences [6] . Therefore, decision-making skill is of great value for responsible professionals.
Given that inadequate communication can result in misunderstanding and conflicts, written and verbal communication skills are important not only for the transfer of information, but also for effective problem-solving and better management of conflict situations. Communication skills are of significant importance for responding to complaints and for making complaints.
The amount and complexity of the tasks is growing in many fields of human activities. Therefore, teamwork is becoming more and more important to achieve required goals.
In order to carry out the appropriate corrective actions and make them effective, comprehensive and detail investigation of the problems should be performed, including the root cause analysis. There are several problem-solving tools and strategies that can be used for accomplishing this task. Based on the results of investigation, appropriate corrective actions should be initiated. This is of paramount importance for all significant deviations.
Managing quality problems and complaintsspecific requirements
When investigating blood product nonconformity or other quality problems, several factors should be taken into consideration depending on the type of the identified or suspected problem. Donor-related factors may include complete blood count parameters (HGB, WBC, PLT, etc.), lipemia, protein content and other laboratory findings, risk behaviours, etc.
Several factors related to blood collection, processing and storage of blood components can have the influence on quality of blood components as length of blood withdrawal, blood flow during withdrawal (venepuncture technique, veins), apheresis procedure (alarms and messages), filtration time, blood separation time and storage conditions. The quality of products and services may also be impaired as a result of equipment failure (HGB determination system, blood mixers, sealers/sterile connection devices, apheresis machines, blood centrifuges and separators, refrigerators/ freezers) or defective materials (blood bags, filters, solutions, labels/adhesives, etc.). Timely detection and putting out of the use of nonconforming materials and equipment are of critical importance in quality assurance of products and services. The assessment of the effect of nonconforming materials or equipment on product and service quality should be performed and all decisions and resulting activities properly documented.
Sometimes quality problems can be attributed to human errors or skills in performing different activities.
When analysing the risks and problems associated with a particular product, materials and equipment, the impact on other products from the same donation, on blood products from other donations of the donor and on the other blood components from the same production 'batch' should be investigated. In this respect, the assessment should be made on the need for product recall.
At each blood establishments, there should be efficient system of timely recall of all blood components suspected of being nonconforming. Written procedure should describe all activities, degree of responsibility of each individual involved and procedure should be harmonized with the existing professional standards and legal provisions. Full traceability of blood components throughout the entire transfusion chain is prerequisite for the efficient recall procedure.
Recall of blood components is most frequently required because of the postdonation information on donor risks, deviation from the prescribed blood component quality detected upon issuing, results of donor testing that may suggest possible risk of issued blood components and reported adverse events or reactions pointing to nonconformity of other products from the same donation or production batch [7] [8] [9] . Product recalls are relatively frequent in transfusion medicine. This is mainly the consequence of biological origin of blood products and specific risks associated with their use.
Serious adverse events and reactions should be reported to the national authorities according to the legal provisions.
Causes of quality problems
In blood banks, quality problems are often manifested on blood products, and possible causes include nonconformities related to the biological origin of blood components (lipemia, haemolysis, clots, aggregates, etc.), human errors, suboptimal planning and organization of work, poor quality of materials and equipment used in product realization [10] . In hospital transfusion units, problems are most commonly related to pre-transfusion testing, particularly errors in pre-analytical phase and to the selection and issuing of blood components for transfusion. Some problems in transfusion medicine are related to clinical transfusion practice and activities that are not directly under the jurisdiction of blood transfusion service (BTS); however, BTS can affect them through hospital transfusion committees, education of clinical staff and so on.
Below are discussed some of the most common nonconformities and quality problems in blood bank activities, using Croatian Institute of Transfusion Medicine (CITM) data. Blood collection is important segment of the transfusion chain, with many critical sites influencing quality and safety of blood components. Fig. 1 is Pareto chart showing the distribution of nonconformities in the process of blood collection, using the CITM data for the year 2017.
Failed collections related to venepuncture, postdonation information (PDI), double venepunctures, nonconformities during apheresis and errors were identified as five leading types of nonconformities representing almost 80% of their total number.
Collection failures represent negative motivational factor for blood donors and economical loss for blood banks. According to the Croatian study published in 2015, the frequency of collection failures greatly depends on the experience of collection staff and the time spent on their education and training [11] . Results of this study suggest that about 1 year is necessary for newly employed workers to acquire necessary skills and to reach the same level of collection failures as their experienced colleagues. Venepuncture failures should be recognized by the quality system as an important quality indicator and its monitoring as a valuable tool for improving the quality of blood components and donor satisfaction.
Despite numerous sensitive tests introduced in screening of donated blood, donor selection process is still very important to ensure the safety of transfusion treatment. Besides safeguarding patients, selection process is also aimed at protecting donor health and well-being. Clearly defined selection criteria, standardized questionnaire, donor education, encouraging blood donors to inform blood bank of any information on health status indicating risk of donated blood are main components of this process. However, blood collection centres are also frequently faced with postdonation information (PDI) on deferrable donor history that was not revealed on time but on the next or even after several donations [12] . Such information is challenging since most of the components are already transfused. When postdonation information is reported, risk assessment should be performed to assess the safety of blood donor and quality/safety of blood components. Close collaboration with hospital blood banks and clinicians is required during the implementation of recall and/or look-back procedures. Informing plasma fractionators about PDI should be defined in the written contract and in line with the legal provisions. Decision on the suitability of blood donors for future donations should be made and donor counselling provided accordingly. Data on PDI should be used for education of blood donors and collection staff, in order to reduce the number of these events and to improve selection process. Double venepuncture is venepuncture repeated after first unsuccessful attempt [13] . Although most of the repeated venepunctures result in adequate donation, monitoring of such events is important segment of donor haemovigilance. As in the case of collection failures, double venepunctures can have negative influence on donor motivation.
Nonconformities occurring during apheresis procedures can be roughly divided into three categories: those associated with donors, with apheresis kits and with the devices. Many adverse events, reactions or quality problems occurring during apheresis are similar to those occurring during whole blood collection. However, there are some specificities, mostly related to the complexity and duration of the procedure.
According to the study investigating errors in blood establishments, about half of all errors occurred at the department for blood collection [14] . This finding was explained by a series of specific characteristics related to this segment of the work in blood establishment: various activities involving numerous participants, mostly manual processes that largely depend on the experience and skills of technicians, blood is collected at blood establishments and at mobile sessions implying constantly changing environmental conditions that require frequent adjustments of work organization. Figure 2 shows Pareto analysis of nonconformities in processes of blood component preparation, storage and quality assessment at CITM in 2017.
Outdated blood components are the leading type of nonconformity according to this analysis. Considering limited supplies of human blood, blood components are considered to be valuable resource that should be managed with great responsibility. That includes careful planning of blood collection and effective stock management. The ultimate goal is low discard rate of blood components [15, 16] . At CITM, significant reduction in outdated platelet concentrates has been achieved by changing the method of platelet preparation from PRP to buffy-coat method. This change has allowed better planning of platelet concentrate stock.
According to the CITM data, lipemia in blood components is not uncommon finding during the in-process control. However, the literature data about the frequency of lipemia differ significantly [17, 18] . This is probably the consequence of different methods used in assessing lipemia, different tolerance limits (also depending on the use of plasma: clinical use vs. fractionation), different organizations of donor sessions, counselling and education of blood donors. According to CITM experience, continuous education and counselling of blood donors is effective method in decreasing this type of nonconformity [19] .
The fundamental role of blood establishments is to provide quality, effective and safe blood products for transfusion treatment. Continuous quality control of blood components should provide the evidence that the process is capable of providing the blood components of required quality. This is achieved by measuring different parameters and to assess whether results obtained comply with the specified requirements. In case of the nonconforming quality control results, decision should be made about the respective blood product(s). Investigation of the causes and additional testing is required to determine whether deviation is due to the accidental process variation or the consequence of the system problem requiring root cause analysis and appropriate corrective actions. For most types of blood component nonconformities, the decision will be made to discard the product. However, sometimes it is possible to revise blood component to meet the specified requirements. This should be confirmed by repeated testing. Some of the nonconforming products may be used for purposes other than for clinical use (for example in bacteriological control) [10] . In exceptional situations, some non-standard blood components may be released. This should be well documented and approved by designated person in the blood establishment and traceability should be ensured [5] .
Product damage is usually detected on frozen blood components. Increased fragility caused by low temperature makes these blood components susceptible to damage during handling and storage. However, some blood components are damaged during preparation (centrifugation, etc.) or accidentally (slip out, etc.). Measures should be taken to prevent product damage by improving handling and applying protective packaging for frozen blood components.
Complaints
Even with the maximum commitment to quality, not all products and services are always in line with the customer requirements and expectations. Therefore, complaints are valuable source of information about the customer satisfaction and quality level of products and services they receive [20] . Complaints need not only have negative consequences for the organization. They should also be perceived as the potential for identifying opportunities for improvement. Solving the problems that led to the complaint, gives customers a sense of trust in further collaboration.
Managing complaints in healthcare institutions has a special dimension, given their primary role in maintenance or improvement of the health. Each complaint should be carefully investigated, and all activities clearly defined, taking also into consideration legal requirements.
When quality or safety problems are detected or suspected in the course of complaint investigation, consideration should be given to the possible impact on other blood components and the need for recall.
Partnership with the costumers and collaboration in resolving the complaint is important for the effectiveness of the procedure. 
Conclusion
Bearing in mind biological origin of blood components and consequential risks associated with their use, transfusion therapy is very safe procedure. Numerous scientific and technological innovations have been implemented in all segments of transfusion medicine, significantly contributed to the quality and safety of blood components. In parallel, great efforts were invested in the implementation of quality system in blood establishments using standards and specifications best suited for transfusion medicine. Despite all the efforts and achievements, even the best organized and managed systems are sometimes faced with quality problems and complaints. Timely identification of problems and their causes and adequate problem-solving is a prerequisite for the implementation of effective corrective actions and continuous quality improvement.
